Works cited by this work

298 works

Work: Pyroptosis-inducing nanomedicines: A dual-mode therapeutic framework for apoptosis-resistant lung cancer

Targeting the proliferation of glioblastoma cells and enhancement of doxorubicin and temozolomide cytotoxicity through inhibition of PFKFB4 and HMOX1 genes with siRNAs
Hamzeh J. Al‐Ameer, Malek Zihlif, Ahmed O. Maslat +13
Article202510 citations
ABI
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott +26
Article20109 citations
ABI
Polymeric Nanoparticles for Drug Delivery
Maximilian A. Beach, Umeka Nayanathara, Yanting Gao +4
Review article20247 citations
ABI
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Yoshiko Iwai, Masayoshi Ishida, Yoshimasa Tanaka +3
Article20025 citations
ABI
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Robert D. Schreiber, Lloyd J. Old, Mark J. Smyth
Review article20115 citations
ABI
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Dung T. Le, Jennifer N. Uram, Hao Wang +32
Article20155 citations
ABI
Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade
Peng Li, Deepak Nijhawan, I. Imawati Budihardjo +4
Article19974 citations
ABI
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Jérôme Galon, Anne Costes, Fátima Sánchez‐Cabo +13
Article20064 citations
ABI
Exploration of the protein and pharmacological landscape of monkeypox virus treatment: from entry point to end point
Cena Aram, Maryam Barancheshmeh, Ali Alishvandi +6
Article20254 citations
ABI
Pro-inflammatory programmed cell death
Brad T. Cookson, Molly A. Brennan
Other20013 citations
ABI
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
Andriy Marusyk, Michalina Janiszewska, Kornélia Polyák
Review article20203 citations
ABI
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Julie R. Brahmer, Karen L. Reckamp, Paul Baas +22
Article20153 citations
ABI
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Jianjin Shi, Yue Zhao, Kun Wang +7
Article20153 citations
ABI
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
Nobuhiko Kayagaki, Irma B. Stowe, Bettina L. Lee +22
Article20153 citations
ABI
Inflammasomes: mechanism of assembly, regulation and signalling
Petr Brož, Vishva M. Dixit
Review article20163 citations
ABI
An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells
Ivan Zanoni, Yunhao Tan, Marco Di Gioia +8
Article20163 citations
ABI
Breast cancer: pathogenesis and treatments
Xin Xiong, Lewei Zheng, Yu‐Qiang Ding +7
Review article20253 citations
ABI
An update on the regulatory mechanisms of NLRP3 inflammasome activation
Seungwha Paik, Jin Kyung Kim, Prashanta Silwal +2
Review article20213 citations
ABI
Enhancement of Antitumor Immunity by CTLA-4 Blockade
Dana R. Leach, Matthew F. Krummel, James P. Allison
Article19963 citations
ABI
Gene regulation by non-Coding RNAs in infertility: a mechanistic review
AmirHossien Borji, Cena Aram, Fatemeh Ziyadloo +6
Article20253 citations
ABI
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jérôme Galon, Daniela Bruni
Review article20192 citations
ABI
Role of pyroptosis in inflammation and cancer
Wei Xiang, Feng Xie, Xiaoxue Zhou +7
Review article20222 citations
ABI
Immunotherapy of targeting MDSCs in tumor microenvironment
Hongshu Sui, Shengyi Dongye, Xiaocui Liu +11
Review article20222 citations
ABI
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan, Andrew J.S. Furness, Rachel Rosenthal +33
Article20162 citations
ABI
Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine
Zahra Izadiyan, Misni Misran, Katayoon Kalantari +5
Review article20252 citations
ABI